CANDEPRESSIN Trademark

Trademark Overview

On Saturday, October 14, 2006, a trademark application was filed for CANDEPRESSIN with the United States Patent and Trademark Office. The USPTO has given the CANDEPRESSIN trademark a serial number of 77021350. The federal status of this trademark filing is REGISTERED AND RENEWED as of Friday, April 27, 2018. This trademark is owned by Liptis Laboratories, Inc.. The CANDEPRESSIN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of hypertension
candepressin

General Information

Serial Number77021350
Word MarkCANDEPRESSIN
Filing DateSaturday, October 14, 2006
Status800 - REGISTERED AND RENEWED
Status DateFriday, April 27, 2018
Registration Number3409811
Registration DateTuesday, April 8, 2008
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 22, 2007

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of hypertension

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, October 18, 2006
Primary Code005
First Use Anywhere DateSaturday, December 15, 2007
First Use In Commerce DateFriday, February 1, 2008

Trademark Owner History

Party NameLIPTIS PHARMACEUTICALS USA, INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressSpring Valley, NY 10977
Party NameLiptis Laboratories, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBronx, NY 11415
Party NameLiptis Laboratories, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBronx, NY 11415
Party NameLiptis Laboratories, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBronx, NY 11415

Trademark Events

Event DateEvent Description
Friday, April 27, 2018NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Friday, April 27, 2018REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Friday, April 27, 2018REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Thursday, April 19, 2018CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, April 9, 2018TEAS SECTION 8 & 9 RECEIVED
Saturday, April 8, 2017COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Tuesday, October 21, 2014TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, October 10, 2013NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Thursday, October 10, 2013REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Thursday, October 3, 2013REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Thursday, October 10, 2013CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, October 3, 2013TEAS SECTION 8 & 15 RECEIVED
Thursday, July 25, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, July 25, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, September 3, 2008AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, April 8, 2008REGISTERED-PRINCIPAL REGISTER
Tuesday, March 4, 2008LAW OFFICE REGISTRATION REVIEW COMPLETED
Monday, March 3, 2008ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, March 3, 2008STATEMENT OF USE PROCESSING COMPLETE
Thursday, February 7, 2008USE AMENDMENT FILED
Thursday, February 7, 2008TEAS STATEMENT OF USE RECEIVED
Tuesday, August 14, 2007NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 22, 2007PUBLISHED FOR OPPOSITION
Wednesday, May 2, 2007NOTICE OF PUBLICATION
Tuesday, March 27, 2007LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, March 27, 2007ASSIGNED TO LIE
Friday, March 2, 2007APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 28, 2007ASSIGNED TO EXAMINER
Wednesday, October 18, 2006NEW APPLICATION ENTERED IN TRAM

Related Keywords

candepressin hypertension treatment preparations pharmaceutical